159 related articles for article (PubMed ID: 9054667)
1. Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines.
Dirks W; Schöne S; Uphoff C; Quentmeier H; Pradella S; Drexler HG
Br J Haematol; 1997 Mar; 96(3):584-93. PubMed ID: 9054667
[TBL] [Abstract][Full Text] [Related]
2. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
3. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines.
Komada Y; Inaba H; Zhou YW; Zhang XL; Tanaka S; Azuma E; Sakurai M
Br J Haematol; 1997 Nov; 99(2):325-30. PubMed ID: 9375749
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.
Beltinger C; Böhler T; Karawajew L; Ludwig WD; Schrappe M; Debatin KM
Br J Haematol; 1998 Aug; 102(3):722-8. PubMed ID: 9722299
[TBL] [Abstract][Full Text] [Related]
5. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
6. Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells.
Karawajew L; Wuchter C; Ruppert V; Drexler H; Gruss HJ; Dörken B; Ludwig WD
Leukemia; 1997 Aug; 11(8):1245-52. PubMed ID: 9264377
[TBL] [Abstract][Full Text] [Related]
7. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells.
Friesen C; Fulda S; Debatin KM
Leukemia; 1997 Nov; 11(11):1833-41. PubMed ID: 9369415
[TBL] [Abstract][Full Text] [Related]
8. Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line.
Irisarri M; Plumas J; Bonnefoix T; Jacob MC; Roucard C; Pasquier MA; Sotto JJ; Lajmanovich A
Leukemia; 2000 Dec; 14(12):2149-58. PubMed ID: 11187905
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.
Friesen C; Herr I; Krammer PH; Debatin KM
Nat Med; 1996 May; 2(5):574-7. PubMed ID: 8616718
[TBL] [Abstract][Full Text] [Related]
10. Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells.
Komada Y; Zhou YW; Zhang XL; Chen TX; Tanaka S; Azuma E; Sakurai M
Br J Haematol; 1997 Jan; 96(1):147-57. PubMed ID: 9012700
[TBL] [Abstract][Full Text] [Related]
11. Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines.
Fellenberg J; Mau H; Scheuerpflug C; Ewerbeck V; Debatin KM
Int J Cancer; 1997 Jul; 72(3):536-42. PubMed ID: 9247301
[TBL] [Abstract][Full Text] [Related]
12. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.
Plumas J; Jacob MC; Chaperot L; Molens JP; Sotto JJ; Bensa JC
Blood; 1998 Apr; 91(8):2875-85. PubMed ID: 9531598
[TBL] [Abstract][Full Text] [Related]
13. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
[TBL] [Abstract][Full Text] [Related]
14. Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells.
Lajmanovich A; Irisarri M; Molens JP; Pasquier MA; Sotto JJ; Bensa JC; Leroux D; Plumas J
Br J Haematol; 2004 Mar; 124(6):746-53. PubMed ID: 15009062
[TBL] [Abstract][Full Text] [Related]
15. CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells.
Tan L; Zhang C; Dematos J; Kuang L; Jung JU; Liang X
J Virol; 2016 Nov; 90(21):9782-9796. PubMed ID: 27558422
[TBL] [Abstract][Full Text] [Related]
16. Ceramide induces apoptosis in neuroblastoma cell cultures resistant to CD95 (Fas/APO-1)-mediated apoptosis.
Schaefer JT; Barthlen W; Schweizer P
J Pediatr Surg; 2000 Mar; 35(3):473-9. PubMed ID: 10726692
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system.
McGahon AJ; Costa Pereira AP; Daly L; Cotter TG
Br J Haematol; 1998 Jun; 101(3):539-47. PubMed ID: 9633899
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
[TBL] [Abstract][Full Text] [Related]
19. Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95.
Re D; Hofmann A; Wolf J; Diehl V; Staratschek-Jox A
Exp Hematol; 2000 Jan; 28(1):31-5. PubMed ID: 10658674
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
